HDAC9 and pulmonary fibrosis: With regard to lung fibrosis, Sanders and coworkers could show that the hydroxamic acid-based pan-HDAC inhibitor SAHA decreased lung fibrosis and improved lung function in bleomycin-treated mice [33].